Literature DB >> 31337668

Acute versus chronic myocardial injury and long-term outcomes.

Erik Kadesjö1, Andreas Roos1, Anwar Siddiqui1, Liyew Desta2, Magnus Lundbäck3, Martin J Holzmann1.   

Abstract

OBJECTIVE: There is a paucity of data regarding prognosis in patients with acute versus chronic myocardial injury for long-term outcomes. We hypothesised that patients with chronic myocardial injury have a similar long-term prognosis as patients with acute myocardial injury.
METHODS: In an observational cohort study of 22 589 patients who had high-sensitivity cardiac troponin T (hs-cTnT) measured in the emergency department during 2011-2014, we identified all patients with level >14 ng/L and categorised them as acute myocardial injury, type 1 myocardial infarction (T1MI), type 2 myocardial infarction (T2MI) or chronic myocardial injury through adjudication. We estimated adjusted HRs with 95% CIs for the primary outcome all-cause mortality and secondary outcomes MI, and heart failure in patients with acute myocardial injury, T1MI and T2MI compared with chronic myocardial injury.
RESULTS: In total, 3853 patients were included. During 3.9 (±2) years of follow-up, 48%, 24%, 44% and 49% of patients with acute myocardial injury, T1MI, T2MI and chronic myocardial injury died, respectively. Patients with acute myocardial injury had higher adjusted risks of death (1.21, 95% CI 1.08 to 1.36) and heart failure (1.24, 95% CI 1.07 to 1.43), but a similar risk for myocardial infarction (MI) compared with the reference group. Patients with T1MI had a lower adjusted risk of death (0.86, 95% CI 0.74 to 1.00) and higher risk of MI (2.09, 95% CI 1.62 to 2.68), but a similar risk of heart failure. Patients with T2MI had a higher adjusted risk of death (1.46, 95% CI 1.18 to 1.80) and heart failure (1.30, 95% CI 1.00 to 1.69) compared with patients with chronic myocardial injury.
CONCLUSIONS: Absolute long-term risks for death are similar, and adjusted risks are slightly higher, among patients with acute myocardial injury and T2MI, respectively, compared with chronic myocardial injury. The lowest risk of long-term mortality was found in patients with T1MI. Both acute and chronic myocardial injury are associated with very high risks of adverse outcomes. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiac risk factors and prevention; coronary artery disease; epidemiology

Year:  2019        PMID: 31337668     DOI: 10.1136/heartjnl-2019-315036

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  High-Sensitivity Troponin T Testing for Pediatric Patients in the Emergency Department.

Authors:  Alan P Wang; James L Homme; M Yasir Qureshi; Yader Sandoval; Allan S Jaffe
Journal:  Pediatr Cardiol       Date:  2021-11-17       Impact factor: 1.655

2.  Associations between elevated high-sensitive cardiac troponin t and outcomes in patients with acute abdominal pain.

Authors:  Triinu Keskpaik; Peep Talving; Ülle Kirsimägi; Vladislav Mihnovitš; Anni Ruul; Toomas Marandi; Joel Starkopf
Journal:  Eur J Trauma Emerg Surg       Date:  2022-07-20       Impact factor: 2.374

Review 3.  Mediation of Cardiac Macrophage Activity via Auricular Vagal Nerve Stimulation Ameliorates Cardiac Ischemia/Reperfusion Injury.

Authors:  Chee Hooi Chung; Beatrice Bretherton; Satirah Zainalabidin; Susan A Deuchars; Jim Deuchars; Mohd Kaisan Mahadi
Journal:  Front Neurosci       Date:  2020-09-08       Impact factor: 4.677

4.  Cardiac Troponin Assays With Improved Analytical Quality: A Trade-Off Between Enhanced Diagnostic Performance and Reduced Long-Term Prognostic Value.

Authors:  Hilde L Tjora; Ole-Thomas Steiro; Jørund Langørgen; Rune Bjørneklett; Ottar K Nygård; Øyvind Skadberg; Vernon V S Bonarjee; Paul Collinson; Torbjørn Omland; Kjell Vikenes; Kristin M Aakre
Journal:  J Am Heart Assoc       Date:  2020-11-26       Impact factor: 5.501

5.  Treatment With Cardiovascular Medications: Prognosis in Patients With Myocardial Injury.

Authors:  Erik Kadesjö; Andreas Roos; Anwar J Siddiqui; Ulrik Sartipy; Martin J Holzmann
Journal:  J Am Heart Assoc       Date:  2020-12-29       Impact factor: 5.501

6.  Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis.

Authors:  Kyle White; Mansey Kinarivala; Ian Scott
Journal:  BMJ Open       Date:  2022-02-17       Impact factor: 2.692

7.  Temporal Changes of Stable High-Sensitivity Cardiac Troponin T Levels and Prognosis.

Authors:  Andreas Roos; Gustaf Edgren; Martin J Holzmann
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

8.  High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction.

Authors:  Andrew R Chapman; Philip D Adamson; Anoop S V Shah; Atul Anand; Fiona E Strachan; Amy V Ferry; Kuan Ken Lee; Colin Berry; Iain Findlay; Anne Cruikshank; Alan Reid; Alasdair Gray; Paul O Collinson; Fred Apple; David A McAllister; Donogh Maguire; Keith A A Fox; Catalina A Vallejos; Catriona Keerie; Christopher J Weir; David E Newby; Nicholas L Mills
Journal:  Circulation       Date:  2019-10-07       Impact factor: 29.690

Review 9.  Diagnosis, Investigation and Management of Patients with Acute and Chronic Myocardial Injury.

Authors:  Caelan Taggart; Ryan Wereski; Nicholas L Mills; Andrew R Chapman
Journal:  J Clin Med       Date:  2021-05-26       Impact factor: 4.241

10.  Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction.

Authors:  John Hung; Andreas Roos; Erik Kadesjö; David A McAllister; Dorien M Kimenai; Anoop S V Shah; Atul Anand; Fiona E Strachan; Keith A A Fox; Nicholas L Mills; Andrew R Chapman; Martin J Holzmann
Journal:  Eur Heart J       Date:  2021-07-08       Impact factor: 35.855

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.